Adherence to disease-modifying antirheumatic drugs and the effects of exposure misclassification on the risk of hospital admission
Author:
Publisher
Wiley
Subject
Rheumatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/acr.20087/fullpdf
Reference10 articles.
1. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis;Saag;Arthritis Rheum,2008
2. Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor α antagonists;Curtis;Arthritis Rheum,2007
3. Tumor necrosis factor-α antagonist use and heart failure in elderly patients with rheumatoid arthritis;Setoguchi;Am Heart J,2008
4. Serious infection following anti-tumor necrosis factor α therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies;Dixon;Arthritis Rheum,2007
5. Assessment of adherence to and persistence on disease-modifying antirheumatic drugs (DMARDs) in patients with rheumatoid arthritis;Grijalva;Med Care,2007
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Treatment with Targeted Therapy in Patients with Psoriatic Arthritis and Inadequate Response to Methotrexate: Proposal for a Rational Strategy;Rheumatology and Therapy;2024-08-12
2. ADA_ETA_BIO2021: real-world evaluation of adherence, persistence, and cost-effectiveness of originator and biosimilar biologic drugs in the treatment of rheumatoid arthritis: a multicenter study in Italy;Current Medical Research and Opinion;2023-12-02
3. Influence of initial glucocorticoid co-medication on mortality and hospitalization in early inflammatory arthritis: an investigation by record linkage of clinical and administrative databases;Arthritis Research & Therapy;2022-06-16
4. The temporal association between hospital admissions, biological therapy usage and direct health care costs in rheumatoid arthritis patients;Rheumatology International;2021-09-18
5. Adherence to biologic disease-modifying antirheumatic drugs in adult patients with rheumatic diseases;Therapies;2021-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3